ANGELA MARCELINO D.O. NPI 1811256464

NPI Information

  • NPI: 1811256464
  • Provider Name: ANGELA MARCELINO, D.O.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 111 MALTESE DR
    MIDDLETOWN, NY
    ZIP 10940
  • Phone: (845) 342-4774

Map and Directions

Get Directions

NPI Details

Angela Marcelino, D.O. is a hematology and oncology internal medicine in Middletown, NY with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Angela Marcelino, D.O. NPI is 1811256464. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

111 MALTESE DR
MIDDLETOWN, NY
ZIP 10940
Phone: (845) 342-4774

The NPI 1811256464 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, gadoteridol, (prohance multipack), per ml (HCPCS:A9576)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Folic acid level, serum (HCPCS:82746)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Uric acid level, blood (HCPCS:84550)
  • Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Red blood count, automated test (HCPCS:85045)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Detection of infectious agent antibody, quantitative (HCPCS:86317)
  • Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)

The enumeration date for this NPI number is 5/16/2012 and was last updated on 5/20/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology294908NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1294908OTHERNEW YORKNYS LICENSE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.